Background illustration for clinical trials search

Paid Clinical Trials Meridian

Discover 224 paid clinical trials in Meridian, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Boise ID, Spokane WA, Salt Lake City UT, Tacoma WA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase 2, Recruiting

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

for
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Location: Boise ID, Portland OR, Eugene OR, Tacoma WA, Clovis CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06806033

Phase 2, Recruiting

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Boise ID, Spokane WA, Salt Lake City UT, Portland OR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 21

Code: NCT04166409

Phase 3, Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Boise ID, Spokane WA, Salt Lake City UT, Reno NV,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase 3, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Boise ID, Spokane WA, Salt Lake City UT, Reno NV,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

for
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor,
Location: Boise ID, Spokane WA, Salt Lake City UT, Reno NV,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT04322318

Phase 2, Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Boise ID, Spokane WA, Salt Lake City UT, Reno NV,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 22

Code: NCT04726241

Phase 1, Phase 2, Recruiting

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Boise ID, Spokane WA, Salt Lake City UT, Reno NV,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT04684368

Phase 2, Recruiting

Project: Every Child for Younger Patients With Cancer

for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Boise ID, Spokane WA, Salt Lake City UT, Reno NV,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT02402244

Recruiting

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

for
Metastatic Malignant Neoplasm in the Lung,
Location: Boise ID, Spokane WA, Yakima WA, Salt Lake City UT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT05235165

Phase 3, Recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for
Acute Myeloid Leukemia
Location: Boise ID, Spokane WA, Salt Lake City UT, Reno NV,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT04293562

Phase 3, Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

for
Acute Leukemia of Ambiguous Lineage,
Location: Boise ID, Spokane WA, Seattle WA, Sacramento CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 1

Code: NCT06317662

Phase 2, Recruiting

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

for
Parkinson's Disease
Location: Boise ID, Spokane WA, Kirkland WA, Seattle WA,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT02071134

Recruiting

Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A

for
Hemophilia A
Location: Boise ID, Portland OR, Los Angeles CA, Torrance CA,
Sponsor: Green Cross Corporation

Sex: All

Age: 12+

Code: NCT01619046

Phase 3, Recruiting

RevCore for In Stent Thrombosis

for
In-stent Thrombosis
Location: Boise ID, Seattle WA, El Paso TX, Plano TX, Columbus OH,
Sponsor: Inari Medical

Sex: All

Age: 18+

Code: NCT06394739

Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Boise ID, Murray UT, Portland OR, Seattle WA,
Sponsor: PPD Development, LP

Sex: All

Age: 18+

Code: NCT06703073

Phase 2, Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab

for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Boise ID, Murray UT, Portland OR, Seattle WA,
Sponsor: PPD Development, LP

Sex: All

Age: 18+

Code: NCT06701682

Phase 2, Recruiting

ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

for
Atrial Fibrillation
Location: Boise ID, Littleton CO, West Hills CA, Vista CA,
Sponsor: Milestone Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06716021

Phase 3, Recruiting

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

for
Pulmonary Disease, Chronic Obstructive
Location: Boise ID, Reno NV, Henderson NV, Las Vegas NV,
Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT07177339

Phase 3, Recruiting

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

for
Pulmonary Disease, Chronic Obstructive
Location: Boise ID, Las Vegas NV, Aurora CO, El Paso TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT06961214

Phase 3, Recruiting